Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Opko Health Inc
(NQ:
OPK
)
1.290
-0.030 (-2.27%)
Streaming Delayed Price
Updated: 1:30 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Opko Health Inc
< Previous
1
2
3
4
5
Next >
The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision
February 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Lilly's Co-developed Diabetes Drug Jardiance Gets Label Expansion To...
Via
Benzinga
32 Stocks Moving in Friday's Pre-Market Session
February 25, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) rose 54.6% to $7.48 in pre-market trading after gaining around 119% on Thursday. The company recently announced a $12 million private placement...
Via
Benzinga
Recap: OPKO Health Q4 Earnings
February 24, 2022
OPKO Health (NASDAQ:OPK) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings OPKO...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 24, 2022
Gainers Unicycive Therapeutics (NASDAQ:UNCY
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
7 Insider Stocks to Buy as Execs Snap Them Up
February 18, 2022
With equity prices soaring to record levels, many execs have cashed out. Here are the insider stocks where execs are cashing in.
Via
InvestorPlace
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
Executives Buying These 5 Penny Stocks
February 16, 2022
Although US stock futures traded slightly lower this morning, there were a few notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...
Via
Benzinga
10 Best Stocks to Buy for Your Income-Generating Portfolio
January 28, 2022
These 10 stocks to buy provide you with a dividend-income ladder from 1% to 10% yields. And hopefully some capital appreciation as well
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
January 25, 2022
On Tuesday, 88 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Credit Suisse Group (NYSE:CS) was the largest, in terms of market cap...
Via
Benzinga
65 Biggest Movers From Yesterday
January 25, 2022
Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Down 250 Points; OPKO Health Shares Plunge
January 24, 2022
Toward the end of trading Monday, the Dow traded down 1.84% to 33,636.46 while the NASDAQ fell 1.83% to 13,517.61. The S&P also fell, dropping, 1.98% to 4,310.71. The U.S. has...
Via
Benzinga
Mid-Day Market Update: Dow Dips 1000 Points; Exterran Shares Jump
January 24, 2022
Midway through trading Monday, the Dow traded down 3.09% to 33,205.52 while the NASDAQ fell 4.56% to 13,141.60. The S&P also fell, dropping, 3.82% to 4,230.05. The U.S. has...
Via
Benzinga
54 Stocks Moving In Monday's Mid-Day Session
January 24, 2022
Gainers Exterran Corporation (NYSE: EXTN) shares jumped 52.4% to $4.5720 after the company said it would merge with Enerflex to create a premier integrated global provider of...
Via
Benzinga
Pfizer Dives After FDA Rejects Its OPKO-Partnered Rare Disease Treatment
January 24, 2022
Pfizer stock tumbled after the FDA rejected an OPKO-partnered drug.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 24, 2022
Gainers SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 15.0% to $6.3 during Monday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Monday, Jan. 24, 2022: UL, SNAP, OPK, M, IBM
January 24, 2022
Today's 5 Stock Ideas: Unilever (UL) - Shares rose following a media report that hedge fund Trian Partners has built a stake in the company. Snap (SNAP) - Wedbush...
Via
Benzinga
28 Stocks Moving in Monday's Pre-Market Session
January 24, 2022
Gainers BT Brands, Inc. (NASDAQ: BTBD) shares rose 158% to $6.37 in pre-market trading after declining around 12% on Friday. Kohl's Corporation (NYSE: KSS) rose 28.4% to $60...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge
January 24, 2022
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled 450 points in the previous session. Investors are awaiting earnings results...
Via
Benzinga
Pfizer - OPKO Health's Growth Hormone Deficiency Candidate Receives FDA Response Letter
January 24, 2022
The FDA has issued a Complete Response Letter (CRL) to Pfizer Inc (NYSE: PFE) and OPKO Health Inc's (NASDAQ: OPK) somatrogon. Somatrogon...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 18, 2022
Gainers Brickell Biotech (NASDAQ:BBI) shares moved upwards by 71.1% to $0.36 during Tuesday's regular session. Brickell Biotech's stock is trading at a volume of...
Via
Benzinga
Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition
January 18, 2022
Sema4 Holdings Corp (NASDAQ: SMFR) has agreed to acquire OPKO Health Inc's (NASDAQ: OPK) wholly-owned subsidiary, GeneDx Inc, for approximately $623...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
Regulatory decisions by the U.S. Food and Drug Administration in December turned out to be mostly positive. Among the treatment options that were greenlighted in the month were...
Via
Benzinga
Opko Health Posts Data From COVID-19 Trial With Its Kidney Disease Treatment
December 23, 2021
OPKO Health Inc (NASDAQ: OPK) has announced preliminary topline results from its Phase 2 trial with Rayaldee to treat mild-to-moderate COVID-19. This study...
Via
Benzinga
Bulls Find Silver Lining Into the Close
December 20, 2021
While it isn't exactly a ringing endorsement that the market is heading higher, it is an indication that the Grinch hasn't entirely spoiled the fun.
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
December 17, 2021
Gainers Genfit (NASDAQ:GN...
Via
Benzinga
63 Biggest Movers From Friday
December 20, 2021
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Via
Benzinga
28 Stocks Moving In Friday's Mid-Day Session
December 17, 2021
Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc...
Via
Benzinga
OPKO Health Q3 Earnings Ahead Of Expectations
October 29, 2021
OPKO Health Inc (NASDAQ: OPK) reported Q3 revenues were down 10% Y/Y to $385.8 million, beating the consensus of $302.27 million. Revenue from diagnostic services...
Via
Benzinga
Opko Health (OPK) Q3 2021 Earnings Call Transcript
October 29, 2021
OPK earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.